Skip to search formSkip to main contentSkip to account menu

itasetron hydrochloride

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

itasetron

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Intravenous itasetron: establishing the effective dose range for the prophylactic control of acute emesis in cancer patients undergoing high-dose cisplatin chemotherapy.
Nausea and vomiting induced by chemotherapy are a major cause of distress to patients and reduce compliance with potentially… 
1997
1997
Comparison of oral itasetron with oral ondansetron: results of a double-blind, active-controlled phase II study in chemotherapy-naive patients receiving moderately emetogenic chemotherapy.
Itasetron hydrochloride is a new 5-hydroxytryptamine3 (5-HT3) antagonist. Experimental investigations show that orally it is… 
1997
1997
Intravenou (i.v.) itasetron hydrochloride (DAU 6215Cl): An effective alternative to ondansetron (OND)
1997
1997
Itasetron hydrochloride (DAU 6215Cl): A pharmacoklnetlcally unique 5-HT3 antagonist
1997
1997
Oral itasetron hydrochloride (DAU 6215Cl) versus ondansetron (OND): Comparable efficacy at a lower dose
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)